Bristol-Myers (BMY) will host an investor conference call at 8:30 AM, to provide details on Extension of U.S. Agreement for ABILIFY and Establishment of an Oncology Collaboration with Otsuka and related financial updates.

To access the live webcasts, log on to

To hear the live, dial 913-312-0823; confirmation code: 3681495.

For comments and feedback: contact